Rare diseases
Investigational molecules
Locations
Back to Portugal679 clinical trials in Senhora Da Hora, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn's Disease
PortugalStudy for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment
PortugalStudy on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer
PortugalStudy on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients
PortugalStudy on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors
PortugalStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
PortugalStudy Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis
PortugalStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
PortugalStudy on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
PortugalStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
PortugalStudy to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies
PortugalStudy on Alisertib with Hormone Therapy for Patients with HR+, HER2- Recurrent or Metastatic Breast Cancer
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Alzheimer's disease and associated conditions, including studies on psychosis treatment and cognitive decline prevention. Multiple trials exploring migraine prevention with novel therapeutic approaches.
Studies are evaluating both symptomatic relief and disease modification strategies.
Comprehensive research in breast cancer treatments, particularly focusing on HR+/HER2- variants and innovative combination therapies. Advanced studies in non-small cell lung cancer exploring new treatment paradigms.
Trials emphasize targeted therapies and immunotherapy approaches.
Groundbreaking research in severe asthma management and chronic rhinosinusitis. Studies evaluating new treatments for COPD with focus on long-term safety and efficacy.
Emphasis on innovative inhaler combinations and targeted biological treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
